mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival

BACKGROUND: The TRICC0808 trial is a phase II multi-institutional trial that investigated the efficacy of preoperative mFOLFOX6 + bevacizumab (BV) therapy for liver-only metastasis that is unsuitable for upfront resection. The R0 resection rate in the efficacy analysis has been reported to be 44.4%,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasuno, Masamichi, Uetake, Hiroyuki, Ishiguro, Megumi, Mizunuma, Nobuyuki, Komori, Takamichi, Miyata, Go, Shiomi, Akio, Kagimura, Tatsuo, Sugihara, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469677/
https://www.ncbi.nlm.nih.gov/pubmed/30612267
http://dx.doi.org/10.1007/s10147-018-01393-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469677/
https://www.ncbi.nlm.nih.gov/pubmed/30612267
http://dx.doi.org/10.1007/s10147-018-01393-8

Ejemplares similares